全國服務(wù)咨詢熱線：
18438616290
<b id="grzca"><menuitem id="grzca"></menuitem></b>
18438616290
簡要描述：M344 251456-60-7M344 is a potent HDAC inhibitor with IC50 of 100 nM and able to induce cell differentiation.
產(chǎn)品型號：abs47027919廠商性質(zhì)：生產(chǎn)廠家更新時間：2026-01-07訪 問 量：730產(chǎn)品分類
Product Category詳細(xì)介紹
| 品牌 | absin | CAS | 251456-60-7 |
|---|---|---|---|
| 分子式 | C16H25N3O3 | 純度 | 98% |
| 分子量 | 307.39 | 貨號 | abs47027919 |
| 規(guī)格 | 2mg | 供貨周期 | 現(xiàn)貨 |
| 主要用途 | is a potent HDAC | 應(yīng)用領(lǐng)域 | 化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 |
M344 251456-60-7
| 產(chǎn)品描述 | |
| 描述 | M344 is a potent HDAC inhibitor with IC50 of 100 nM and able to induce cell differentiation. |
| 純度 | 98% |
| 儲存/保存方法 | Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | Histone Deacetylase Inhibitor III |
| 外觀 | 白色至淡黃色粉末 |
| 可溶性/溶解性 | Ethanol ：4 mg/mL (13.01 mM) DMSO ：62 mg/mL (201.69 mM) |
| 生物活性 | |
| 靶點(diǎn) | HDAC |
| In vitro(體外研究) | M344 is a potential histone deacetylase (HDAC) inhibitor. BRCA1 mRNA levels are determined by RT-PCR following exposure to increasing concentrations of the HDAC inhibitor M344 alone and in combination with Cisplatin in all 6 cell lines evaluated in this study. With increasing concentrations of M344, there is a dose dependant decrease in BRCA1 mRNA and treatment with both 1 and 5 μM concentrations of M344 resulting in a significant decrease in BRCA1 expression in all cell lines examined. M344 in combination with Cisplatin leads to a decrease in BRCA1 mRNA expression as compared to Cisplatin treatment alone in all cell lines with the exception of A2780s, which is recognized as having potent cytotoxicity to Cisplatin. In the MCF7 cell line, BRCA1 is down regulated at physiological doses of M344 (0.5 μM and 1 μM) but M344 does not have the same inhibitory effect on BRCA1 at the 5.0 μM dose. Co-treatment with Cisplatin and increasing concentrations of M344 reduces BRCA1 protein levels in all breast and ovarian cell lines examined. |
| 參考文獻(xiàn) | |
| 參考文獻(xiàn) |
|
| 研究領(lǐng)域 | |
| 研究領(lǐng)域 | CancerCancer Metabolism CancerTumor biomarkers Drug DiscoverySmall Molecule DrugLead Compound Discovery |
產(chǎn)品咨詢
地址：上海市浦東新區(qū)新浩路58號申江科創(chuàng)園18棟
郵箱：
傳真：